Press release
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing marke
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.
Within this market, hospitals and specialty clinics will remain the largest segment.
Download sample by clicking on MRD testing market
APAC is expected to witness highest growth over the forecast period.
Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056
Explore Our Latest Publications
Hi-Fi System Market
Bearing for Mechanical and Electrical Product
Telecom Electronic Manufacturing Service Market
Timing Device Market
Visual Inspection Microscope Market
Construction Waste Crusher Market
Nonwovens for Construction Market
OSB Panel for Construction Market
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-mrd-testing-market-to-reach-34-billion-by-2031]
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031 here
News-ID: 4000115 • Views: …
More Releases from ABNewswire
Draft Products Revolutionizes UK Home Bars with Exclusive European Craft Beer an …
Leading importer brings authentic German and French craft brewing expertise directly to British beer enthusiasts' homes
LONDON, UK - June 16, 2025 - Draft Products, the UK's premier destination for European craft beer and home bar solutions, announces its continued expansion as the definitive source for authentic continental brewing experiences. Specializing in exclusive 5-liter beer keg systems and premium European craft imports, the company is transforming how British consumers experience draught…
Pompe Disease Market Set for Robust Growth Through 2034, Driven by Breakthrough …
The Pompe disease treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, including Sanofi, Genzyme, Amicus Therapeutics, GeneCradle Therapeutics, Astellas Gene Therapies, Spark Therapeutics, Aro Biotherapeutics, Maze Therapeutics, Valerion Therapeutics, Actus Therapeutics, Roche, and Lacerta Therapeutics, among others.
DelveInsight's "Pompe Disease Market Insight, Epidemiology And Market Forecast - 2034 [https://www.delveinsight.com/report-store/pompe-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers an in-depth understanding of the Pompe disease treatment…
PD-L1 Inhibitors Market Insight, Epidemiology, and Market Forecast - 2034 | Says …
PD-L1 inhibitors have become a vital part of modern cancer therapy by blocking the PD-1/PD-L1 pathway, which tumors use to evade immune detection. By restoring T-cell function, these therapies boost the body's ability to fight cancer. They have shown significant clinical benefit, including durable responses and improved survival, in several cancers such as NSCLC, TNBC, renal cell carcinoma, urothelial carcinoma, and head and neck squamous cell carcinoma.
DelveInsight's "PD-L1 Inhibitors Market…
Oncolytic Virus Market Set to Advance Cancer Immunotherapy Frontier Through 2034 …
The Oncolytic Virus (OV) therapy landscape is evolving rapidly as this novel immuno-oncology strategy gains traction for its ability to selectively infect, replicate within, and destroy cancer cells, while simultaneously stimulating a potent anti-tumor immune response. Unlike traditional cancer treatments, oncolytic viruses offer dual mechanisms of action: direct tumor lysis and immune activation, making them promising candidates for combination regimens in hard-to-treat and resistant tumors.
DelveInsight's "Oncolytic Virus Market Report [https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]"…
More Releases for MRD
MRD (Minimal Residual Disease) Testing Market to Witness Huge Growth by Key Play …
According to Market Study Report, MRD (Minimal Residual Disease) Testing Market provides a comprehensive analysis of the MRD (Minimal Residual Disease) Testing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5228316
The report provides a comprehensive analysis of company profiles listed below:
-…
MRD (Minimal Residual Disease) Testing Market CAGR, Volume and Value 2021-2027 | …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the MRD (Minimal Residual Disease) Testing industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The MRD (Minimal Residual Disease) Testing market survey report has been prepared by conducting market research in a systematic manner. Moreover, the MRD (Minimal…
Major Depressive Disorder Market Is Expand To Touch Perspective Value By 2024 Co …
The research study covers the current scenario and growth prospects of the Major Depressive Disorder market (2020-2024) according to the analysis . This study includes a extensive analysis of the key segments of the industry and also the regional analysis that are taken place throughout the country.
Global Major Depressive Disorder Market Overview:
The report also reveals in-depth details of shifting market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting…
COVID-19 UV Light Solution
New York-based MRD Lighting, a major vendor to the international cruise industry, is developing ultraviolet lighting prototypes to combat airborne and surface-transmitted viruses aboard ships.
The company, which has consistently innovated in providing a wide array of solutions to cruise lines, is working with subject matter experts in the radiological and epidemiology arenas to provide rapid-response capabilities as the Coronavirus increasingly impacts the cruise industry.
"We have been expanding our capabilities and…
Can quantitative chimerism monitoring serve as surrogate marker to predict clini …
A promising method indicates success
Allogeneic stem cell transplantation (HSCT) is an effective therapy for hematopoietic disorders such as Acute Myeloid Leukemia (AML) or the Myelodysplastic Syndrome (MDS). However, imminent relapse remains a serious problem. Routinely, monitoring of minimal residual disease (MRD) by diseases-specific markers such as FLT3, NPM1, BCR-ABL, AML-ETO and others is performed to signify threatening relapse as early as possible. However, a high number of patients lack…
Power Requirements a Vital Consideration for International Major Events
Saint Petersburg, Russia: Aggreko, the world leader in the provision of temporary power and temperature control services will be demonstrating the “efficiency for every stage” concept at SportAccord Convention 2013, as it continues its partnership with the most important event on the international sports business calendar. Aggreko will be exhibiting at the Lenexpo Exhibition Centre in Saint Petersburg, presenting this new concept to senior executives and key decision makers responsible…
